Advertisement
Screener

Trevi Therapeutics, Inc. (TRVI) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Trevi Therapeutics, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Trevi Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 8.25, a 146.21% increase year-over-year.
  • Trevi Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 8.89.
  • Trevi Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 8.76.
  • Trevi Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 6.19.
  • Trevi Therapeutics, Inc. price/book ratio for fiscal 2026 was 8.25.
  • Trevi Therapeutics, Inc. price/book ratio for fiscal 2025 was 8.76.
Available history
2025-06-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-308.25$2.65B$321.51M
2026-03-318.89$1.53B$172.13M
2025-12-318.76$1.61B$183.24M
2025-09-306.19$1.17B$189.79M
2025-06-303.35$665.5M$198.49M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-308.25$2.65B$321.51M
2025-12-318.76$1.61B$183.24M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12